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Abstract
Background: Bacteria of the suborder Corynebacterineae include significant human pathogens such as Mycobacterium
tuberculosis and M. leprae. Drug resistance in mycobacteria is increasingly common making identification of new
antimicrobials a priority. Mycobacteria replicate intracellularly, most commonly within the phagosomes of macrophages,
and bacterial proteins essential for intracellular survival and persistence are particularly attractive targets for intervention
with new generations of anti-mycobacterial drugs.
Methodology/Principal Findings: We have identified a novel gene that, when inactivated, leads to accelerated death of M.
smegmatis within a macrophage cell line in the first eight hours following infection. Complementation of the mutant with
an intact copy of the gene restored survival to near wild type levels. Gene disruption did not affect growth compared to
wild type M. smegmatis in axenic culture or in the presence of low pH or reactive oxygen intermediates, suggesting the
growth defect is not related to increased susceptibility to these stresses. The disrupted gene, MSMEG_5817, is conserved in
all mycobacteria for which genome sequence information is available, and designated Rv0807 in M. tuberculosis. Although
homology searches suggest that MSMEG_5817 is similar to the serine:pyruvate aminotransferase of Brevibacterium linens
suggesting a possible role in glyoxylate metabolism, enzymatic assays comparing activity in wild type and mutant strains
demonstrated no differences in the capacity to metabolize glyoxylate.
Conclusions/Significance: MSMEG_5817 is a previously uncharacterized gene that facilitates intracellular survival of
mycobacteria. Interference with the function of MSMEG_5817 may provide a novel therapeutic approach for control of
mycobacterial pathogens by assisting the host immune system in clearance of persistent intracellular bacteria.
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Introduction
Macrophages are major cellular components of innate host
defence pathways and have roles including the recognition,
ingestion and destruction of foreign microbes including pathogenic
and non-pathogenic Mycobacteria. Pathogenic members of the
genus have developed numerous strategies to evade the antimi-
crobial actions of the macrophage and to survive within this
normally inhospitable cell eventually resulting in disease [1]. The
interactions between the intracellular mycobacterial pathogens,
such as Mycobacterium tuberculosis, and host are central to their
success and have major implications for establishment of disease,
spread of infection and persistence within the host. A characteristic
of many mycobacterial diseases, particularly tuberculosis (TB), is
that the infective pathogen can persist in the host for long periods
of time in either a latent state where bacterial growth is stationary,
or in a metabolically active state that facilitates proliferation. The
World Health Organisation (www.who.int/tb/en) has estimated
that one-third of the world’s population have a latent TB infection
that could potentially be activated given the correct conditions in
an immunocompromised host.
Upon infection, most non-pathogenic microbes are internalised
by host macrophages into a phagosome. Within the phagosome,
the invading microbe is exposed to elevated levels of reactive
oxygen intermediates (ROI) and reactive nitrogen intermediates in
an increasingly hostile environment [2,3,4]. The phagosome
matures and fuses with organelles of the endocytic pathway
acquiring molecular markers that act to acidify the phagocytic
compartment to pH 5, and hydrolytic enzymes that digest its
contents [1]. In contrast, the intracellular mycobacterial pathogen
is able to survive for long periods within the phagosome, creating a
hospitable environment by modulating host-signalling pathways to
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halter vesicular membrane trafficking and phagolysosome forma-
tion. The resulting phagocytic compartments fail to mature, do not
fuse with late endosomes and lysosomes and do not acquire
lysosomal hydrolases [5,6]. Moreover, mycobacterial phagosomes
do not acidify below pH 6–6.5 due to a depletion of vesicular
proton-ATPase (V-ATPase) at the phagosomal membrane [7,8]).
It is widely accepted that mycobacterial cell wall lipids,
phosphatidylinositol mannoside (PIM) and lipoarabinomanann
(LAM) play a major role in blocking phagosomal maturation [9].
LAM is thought to block vesicular trafficking thus inhibiting the
acquisition of late endosomal and lysosomal cargo from the trans-
Golgi network. Conversely, PIM is believed to promote fusion to
early endosomes perhaps to supply nutrients to the phagosome
and maintain a less acidic environment [6,10]. The mycobacterial
genes that mediate these adaptive responses are largely unknown.
In addition to internalization, recognition of mycobacteria by the
host immune system, particularly by members of the Toll-like receptor
(TLR) family of molecular pattern recognition receptors, is a crucial
step for an effective host response. TLR recognition of mycobacteria
or mycobacterial products is particularly important for the production
of the pro- and anti-inflammatory cytokines and chemokines
responsible for the progression or containment of infection.
Identification of the mechanisms used by mycobacteria to
subvert the antibacterial properties of the macrophage is
important for understanding mycobacterial virulence and disease.
The mce1 operon, originally identified in M. tuberculosis [11] but
also present in other pathogenic and non-pathogenic mycobacteria
[12], has been shown to be important in the invasion of the
mammalian host cell and the establishment a persistent infection
in the mouse model [11,13,14]. A number of genes from M.
tuberculosis including a catalase peroxidase, katG and alkylhydroper-
oxide reductase, ahpC have suggested functions in conferring
resistance to ROI [15,16]. Other genes have been implicated in
modulating phagosomal maturation and promoting intracellular
survival including, mycobacterial protein kinase G (pknG) from
pathogenic mycobacteria [17] and a hypothetical gene from M.
marinum, pmiA [18]. Also implicated in intracellular mycobacterial
survival are icl (isocitate lyase), mptpB (tyrosine phosphatase) and
sapM (PI3P phosphatase) from M. tuberculosis [19,20,21].
Previous studies have shown that while M. smegmatis is generally
considered non-pathogenic, it does have a limited capacity to
survive and multiply within macrophages and delay phagosomal
acidification making it a suitable model system to study
intracellular mycobacterial survival [8] [22]. Here, we describe
the intracellular phenotype of M. smegmatis mutants with insertions
in a highly conserved hypothetical gene (MSMEG_5817). The
intracellular survival kinetics of the mutants suggest that
MSMEG_5817 functions in mycobacterial survival in host
macrophages.
Results
Identification of the transposon insertion site in Myco132
and analysis of flanking sequences
In previous studies we screened members of a random Tn611
transposon mutant library of M. smegmatis for a number of different
phenotypes [23,24,25]. Myco132 was originally isolated from this
library based on its altered colony morphology and capacity to
take up dyes from the growth media. To identify the gene
disrupted by the Tn611 element in Myco132, genomic DNA
fragments flanking the transposon insertion site were obtained by
ligation-mediated polymerase chain reaction (LMPCR) [26] and
sequenced. The sequences obtained were assembled and searched
against the M. smegmatis genome (http://cmr.jcvi.org/cgi-bin/
CMR/CmrHomePage.cgi) using the BLAST algorithm. The
gene containing the transposon insertion was identified as
MSMEG_5817, encoding a conserved hypothetical protein of
128 amino acid residues with orthologs in a number of pathogenic
mycobacteria (Table 1).
Sequence analysis of the 59 flanking region revealed a second
gene, immediately upstream of the disrupted MSMEG_5817
gene (Fig. 1). This second gene, identified as MSMEG_5818
encodes a putative virulence factor mammalian cell entry (Mce)
family protein, sharing significant homology at the amino acid
level to mce1A (68%) but is not located within the mce1 operon
in M. smegmatis. In addition to the defining mce domain,
MSMEG_5818 also contains a putative inner membrane
component binding-protein-dependent transport system. Up-
stream of this gene is MSMEG_5819 encoding a putative
pyridoxamine 5-phosphate oxidase and a hypothetical protein-
encoding gene, MSMEG_5820. The sequence flanking the 39 end
of MSMEG_5817 corresponds to MSMEG_5816,e n c o d i n ga
different conserved hypothetical protein. Searches for amino
acid homology did not reveal a MSMEG_5816 ortholog in M.
tuberculosis; instead the closest significant match was to a
conserved hypothetical protein, nfa21710 from Nocardia farcinica
(70%; E=1e
-130). The next two 39 genes are MSMEG_5815 and
MSMEG_5814 encoding betaine aldehyde dehydrogenase (EC
1.2.1.8) and 4-carboxymuconolactone decarboxylase domain
protein (EC 4.1.1.44) respectively. In each case, the three ORFs
identified flanking each side of MSMEG_5817 are transcribed in
the opposite direction to MSMEG_5817. Interestingly, the gene
arrangement in the region defined by these seven ORFs
identified in M. smegmatis diverges from that found in M.
tuberculosis, M. bovis subsp. bovis and M. avium, where arrangement
of the respective MSMEG_5817 orthologs and 39 flanking the
genes is conserved (Fig. 1). Closer inspection of the sequences
flanking the transposon insertion identified the insertion site as
nucleotide 222 of the 387 bp gene (Fig. 2a).
Table 1. Percent amino acid identity and similarity between MSMEG_5817 orthologs.
M. smegmatis M. tuberculosis M. paratuberculosis M. avium M. leprae
M. smegmatis 100 72 70 69 72
M. tuberculosis 66 100 73 74 80
M. paratuberculosis 65 71 100 94 73
M. avium 63 70 93 100 77
M. leprae 62 73 65 70 100
Shaded and unshaded areas indicate % similarity and % identity, respectively.
doi:10.1371/journal.pone.0031788.t001
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Preliminary studies using defective survival in J774A.1 macro-
phages as the readout indicated that Myco132 was unable to
proliferate over a 4 h infection period, unlike several other mutants
selected from the transposon library. To better characterize the
phenotype, intracellular survival of Myco132 in J774A.1 macro-
phages was compared to wild type M. smegmatis mc
2155 (WT) over a
48 h infection period. Following infection, macrophages were
Figure 2. Transposon Tn611 and targeted inactivation of the MSMEG_5817 gene. (A) Insertion site of the Tn611 element in Myco132. (B)
Targeted disruption of MSMEG_5817 by a kanamycin resistance gene in strain Myc85. The insertion of the aphA-3 gene at the unique BstXI site in
MSMEG_5817 is indicated. Position of the probe used for Southern hybridization is shown as a solid horizontal line. Restriction fragments detected by
the probe in WT and Myc85 are shown as broken horizontal lines. (C) Southern hybridization analysis of Myc85. Lane 1, molecular weight markers
with sizes indicated in kilobases (kb); Lane 2, wild-type M. smegmatis genomic DNA digested with ClaI/EcoRV; Lane 3, Myc85 genomic DNA digested
with ClaI/EcoRV.
doi:10.1371/journal.pone.0031788.g002
Figure 1. Schematic representation of the gene arrangement in the region of the M. smegmatis MSMEG_5817 locus and orthologous
regions in M. tuberculosis H37Rv, M. bovis subsp. bovis AF2122/97 and M. avium 104. Arrows indicate the relative direction of transcription.
Shading indicates homologous genes.
doi:10.1371/journal.pone.0031788.g001
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phagocytosed bacteria were removed and the culture initiated. At
each time point, intracellular mycobacteria were released from
J774A.1 macrophages and the viable count determined by
measuring colony-forming units (CFU) of bacteria resident within
macrophages.
Myco132 exhibited a marked reduction in intracellular survival
during the first 24 h of infection compared to WT (Fig. 3a). At 4 h
infection Myco132 (48.0%611.8) showed ,3-fold decrease in
viability compared to WT (146.4%622.7). This difference was
more pronounced at 8 h with the proportion of intracellular
Myco132 (54.7%616.8) bacteria recovered from J774A.1 macro-
phages still significantly lower than WT (195.7%636.6). By 24 h
all strains were equally sensitive to macrophage killing.
Targeted disruption of MSMEG_5817 and
complementation
To confirm that the macrophage survival defect observed for
Myco132 was due solely to the disruption of the MSMEG_5817
gene, we constructed a new strain in which MSMEG_5817 was
disrupted by a kanamycin resistance gene (Fig. 2b) using a two-step
recombination strategy (see Materials and Methods). Briefly, the
MSMEG_5817 gene was PCR amplified, cloned into pUC18 [27]
and disrupted by insertion of a kanamycin-resistance gene at a
unique BstXI site. This fragment was subcloned into the
temperature-sensitive vector pPR27 [28] followed by introduction
into M. smegmatis and selection for single crossovers at the non-
permissive temperature. Double crossovers were then derived by
selection of plates containing kanamycin and sucrose. A potential
MSMEG_5817:aphA3 mutant was confirmed using Southern
hybridization (Fig. 2c) and designated Myc85. To complement
Myc85, the MSMEG_5817 gene was PCR amplified and cloned
into a modified version of the mycobacterial expression vector
pMV261 [29] in which the kanamycin resistance gene had been
replaced by a gentamycin resistance gene. This complementation
plasmid was introduced into Myc85, creating Myc85c.
To determine the capacity of the targeted knockout and
complementation strain to survive in vivo, the macrophage survival
experiments described above for Myco132 were repeated using
Myc85 and Myc85c (Fig. 3a). At 4 h infection Myc85
(49.1%617.7) showed ,3-fold decrease in viability compared to
WT (146.4%622.7). This difference was more pronounced at 8 h
with the proportion of intracellular Myc85 (29.9%612.0) bacteria
recovered from J774A.1 macrophages still significantly lower than
WT (195.7%636.6). Thus the capacity of Myc85 to survive in
J774A.1 macrophages was found to strongly resemble that of
Myco132. In contrast, the early survival kinetics of Myc85c closely
resembled those observed for WT, suggesting that intracellular
survival had been restored to WT levels by expression of the
MSMEG_5817 gene product. Interestingly, Myc85c was still viable
at 48 h post infection while WT, Myco132 and Myc85 had been
cleared by this time point (Fig. 3a).
The observed failure of Myco132 and Myc85 to proliferate in
macrophages could reflect a specific intracellular growth defect or
a more general problem with replication. To determine this we
examined their capacity to grow in axenic, liquid broth cultures.
When cultured in BHI broth, WT, Myco132, Myc85 and Myc85c
showed similar rates of growth over a 42 h period (Fig. 3b). Since
Myco132 and Myc85 behaved almost identically in vitro and in vivo,
we selected Myco132 as the representative MSMEG_5817 mutant
for all subsequent analyses.
To determine whether the observed reduction in intracellular
survival of Myco132 could be accounted for by antimicrobial
mechanisms of macrophages, the sensitivity of WT and Myco132
strains to low pH or the presence of ROI was examined in vitro
over a 6 h growth period. The growth rate in acidic conditions was
compared in BHI broth over a pH range that included pH 7,
pH 5 and pH 3 (Fig. 4a). Similarly, to assess the impact of ROI,
H2O2 was added to BHI (pH 5) at various concentrations (Fig. 4b).
In each case growth of Myco132 did not differ significantly from
WT in response to either acid or H2O2 stress.
To assess acid sensitivity in more detail, Myco132 was also
compared to WT for differences in intracellular pH regulation,
sensitivity to protonophores at low pH and acid stress survival.
Firstly, the regulation of pH homeostatis by M. smegmatis was
studied by determining the intracellular pH as a function of
external pH. Internal pH was measured by [
14C] benzoic acid
equilibration in cells oxidising glucose but there were no significant
differences observed between WT and Myco132 (data not shown).
Secondly, acid sensitive strains should be unable to grow in 7H9
medium (pH 5.0) in the presence of 5 mM carbonyl cyanide m-
chlorophenylhydrazone (CCCP), a concentration that is not
inhibitory to the WT. However, Myco132 showed comparable
growth to WT at pH 5.0 at 1 to 8 mM CCCP. Finally, cells were
Figure 3. Growth of WT M. smegmatis, Myco132, Myc85 and
Myc85c inside J774A.1 macrophages and in vitro. (A) Intracellular
survival of WT, Myco132, Myc85 and Myc85c in J774A.1 macrophages
over a 48 h infection (n=3–19). Numbers of intracellular bacteria are
shown as a percentage of the numbers detected at t=0 h (% survival).
Significant differences were determined by Student’s t-test and are
indicated by ** (p,0.05) between WT/Myc85c and Myco132/Myc85 and
## (p,0.05) between WT and Myc85c. Error bars represent SEM. (B) In
vitro growth of WT, Myco132, Myc85 and Myc85c in BHI (n=3). Error
bars represent SD.
doi:10.1371/journal.pone.0031788.g003
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stress survival. WT cultures showed a decline in viability of 23% in
the first 4 hr at pH 2.7 and an 80% decline after 6 hours.
Myco132 viability declined by 42% within 4 hours and was not
considered significantly different from WT. Collectively, our data
suggest that the failure of Myco132 to survive intracellularly was
not due to increased sensitivity to conditions encountered within
macrophages.
Phagocytosis of Myco132 is not reduced compared to
wild type bacteria
To determine whether the reduced number of intracellular
Myco132 observed was due to a defect in the attachment or uptake
of the mutant bacteria by macrophages, WT and Myco132 bacteria
were fluorescently stained with SYTO9 and SYTO62, respectively,
and presented to macrophage cells simultaneously. FACS was then
used to detect macrophages infected with one or both strains. Dye
swaps were also performed to ensure the fluorescent label used did
not differentially influence phagocytosis. The analysis revealed that
phagocytosis of Myco132 was not deficient. Whilst the number of
macrophages infected with Myco132 alone was at least double that
observed for WT (Fig. 5), this was not statistically significant.
Similarly when macrophages were presented with both strains
simultaneously, phagocytosis was not biased towards either WT or
mutant, suggesting that the mutant is not defective in attachment or
uptake but rather in its ability to survive once internalised by the
macrophage.
Myco132 causes increased NF-kB activation in
macrophage cells
Although phagocytosed as well or more than WT M. smegmatis,
Myco132 showed a marked defect in early cellular survival.
Besides phagocytosis, recognition of mycobacteria by TLRs can
induce several signalling pathways that converge at the level of
NF-kB activation and mediate cell activation and cytokine
production. Therefore, using an NF-kB-dependant reporter gene
system as a measure of TLR-dependant activation, we investigated
whether Myco132 was able to activate NF-kB to a similar level as
WT M. smegmatis. Whereas both M. smegmatis and Myco132
induced a significant increase in NF-kB activation above
Figure 4. Growth of WT M. smegmatis and Myco132 under stress
conditions. (A) In vitro growth of WT and Myco132 at different pH
(n=3–4). Error bars represent SD. (B) In vitro growth of WT and Myco132
at pH 5 in the presence of H2O2 for 6 h (n=3–4). Error bars represent
SD.
doi:10.1371/journal.pone.0031788.g004
Figure 5. The mean number of J774A.1 cells infected with
SYTO9 or SYTO62 stained WT and Myco132. Infected macro-
phage cells with phagosomes harbouring either WT or Myco132 alone,
or both M. smegmatis strains simultaneously was determined from
11,000–15,000 J774A.1 cells from two experiments by FACS. Error bars
represent SD.
doi:10.1371/journal.pone.0031788.g005
Figure 6. NF-kB activation in macrophages infected with WT M.
smegmatis or Myco132. RAW264.7 mouse macrophage cells stably
expressing the NF-kB-dependent ELAM-luciferase reporter construct
were exposed to 10
5 cfu formaldehyde-killed wild-type M. smegmatis or
Myco132 for 3.5 hours. Mean relative stimulation of luciferase activity
for three biological replicates per strain 6 SD for a representative
experiment from 3 experiments, each performed in triplicate, is shown.
Significant differences were determined by Student’s t-test and are
indicated by * (p,0.05).
doi:10.1371/journal.pone.0031788.g006
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increase in NF-kB activation demonstrated with Myco132
compared to a WT M. smegmatis control.
Similarity searches of MSMEG_5817
BLASTP searches of the non-redundant protein sequence (nr)
database (http://www.ncbi.nlm.nih.gov/BLAST/) were per-
formed in an attempt to identify other proteins with homology
to MSMEG_5817 to gain insight into its possible function. These
searches yielded 37 significant matches, 36 of which were to
unknown hypothetical proteins from various species of Mycobac-
terium, Rhodococcus and Corynebacterium. Significant homology (62%
similarity and 46% identity; E=6e-15) was also detected to
serine:pyruvate aminotransferase (SPT), also known as alanine:
glyoxylate aminotransferase (AGT) from Brevibacterium linens BL2
(accession ZP_00381195) (Fig. 7a). Comparison of SPT/AGTs
from a number of organisms revealed a conserved aminotransfer-
ase class V domain. This domain is absent in both MSMEG_5817
and the B. linens predicted SPT/AGT.
MSMEG_5817 is transcribed in M. smegmatis and encodes
a protein of unknown function
The possibility that MSMEG_5817 encodes a functional AGT,
mediating transfer of the amino group of alanine to glyoxylate to
form glycine and pyruvate was investigated. To test this, alanine
and glyoxylate were added to enzyme extracts prepared from WT
and Myco132 lysates. Pyruvate formed by AGT was then
measured by spectrophotometric NADH determination using
LDH. To ensure the enzyme preparation did not contain other
substrates that would permit formation of pyruvate, the reaction
was also performed in the absence of glyoxylate or alanine. The
relative rate of pyruvate reduction determined by the extinction of
NADH in the subsequent LDH assay was very similar for WT and
Myco132 suggesting that AGT activity in the two strains was not
noticeably different (Fig. 7b). We concluded that MSMEG_5817
does not encode a functional AGT under the conditions tested.
Finally, RT-PCR was performed to detect MSMEG_5817
mRNA in intra- and extracellular samples of M. smegmatis WT
and Myco132 strains. In WT, amplification was achieved from
Figure 7. A. ClustalW amino acid sequence alignment of MSMEG_5817 and B. linens SPT/AGT (accession NZ_AAGP01000002).
Identical amino acid residues are denoted by black type, conserved residues by grey. B. The rate of pyruvate reduction in WT and Myco132
M. smegmatis strains (n=4). Negative controls were performed in the absence of glyoxylate or alanine.
doi:10.1371/journal.pone.0031788.g007
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PCR product in the RT minus controls confirmed amplification
was achieved from cDNA and not gDNA. Amplification was not
detected in either the intra- or extracellular Myco132 samples
suggesting that disruption of MSMEG_5817 in the mutant
abolished transcription of this gene.
Discussion
In this study we have identified a novel gene from M. smegmatis
involved in intracellular survival in host macrophages. Although M.
smegmatis is considered non-pathogenic, it has been shown to behave
in a pathogen-like manner by manipulating the host cell during the
initial stages of infection to delay acidification and recruitment of V-
ATPase to the phagosome [8,22]. M. smegmatis has been used as a
model species in previous studies to successfully identify genetic loci
implicated in intracellular survival [26]. Here we have used the
J774A.1 macrophage cell line derived from a tumour of a BALB/c
adult female mouse for our infection model. J774A.1 macrophages
have been used widely to study intracellular mycobacterial survival
and host interactions [6,8,18,20,22]. We report that M. smegmatis
mutant Myco132 carries a transposon inserted into MSMEG_5817,
a gene encoding a hypothetical protein of unknown function. This
mutant exhibits reduced intracellular survival in J774A.1 macro-
phages. This defect in growth is specific to the phagosomal
compartment and is not observed in vitro broth culture. Further-
more, this defect cannot be attributed to an increased sensitivity of
Myco132 to acidic pH or the presence of ROI.
The survival kinetics observed for WT M. smegmatis were in
general agreement with the three rapid killing phases described by
Anes et al over a 48 h infection period [22]. Myco132 and Myc85
were more sensitive to the antimicrobial macrophage environment
than WT during the initial phase of killing with significantly fewer
intracellular bacteria surviving beyond 4 h. In fact, while WT
undergoes an intracellular growth phase between killing phases 1
and 2, Myco132 does not recover as intracellular survival
continues to decline. During the second phase of killing, WT
and mutant strains were almost completely eliminated until finally
disappearing during the third killing phase when the macrophage
achieves complete clearance at 48 h. Complementation of the
mutant with a plasmid-encoded copy of the MSMEG_5817 gene
restored early survival capacity to Myc85, but also produced a
strain that persisted longer than either WT or the mutant strains.
Since multiple plasmid-encoded copies of MSMEG_5817 are likely
to result in overexpression of the gene, this finding could indicate a
role for MSMEG_5817 in persistence due to overproduction of
MSMEG_5817 in the complemented strain.
MSMEG_5817 was identified as the gene disrupted by the
transposon insertion and has orthologs in both pathogenic and
non-pathogenic mycobacteria. This is consistent with the evolving
view of pathogenicity based on genomic analysis that has shown
that many virulence factors are present in both virulent and non-
virulent species, presumably as a consequence of similarity in
selective forces under differing environmental conditions [30]. In
M. tuberculosis, the MSMEG_5817 ortholog Rv0807 was not
detected as being essential for survival in macrophages in a broad
genomic screen using a transposon site hybridisation (TraSH)
approach [31]. However, examination of the data suggests that the
small size of the gene may have precluded it from the analysis due
to a lack of mariner insertions, highlighting a possible limitation of
the TraSH approach. Rv0807 is also not essential for growth of M.
tuberculosis [32], suggesting that MSMEG_5817 may contribute to
intracellular survival through a mechanism common to pathogenic
and non-pathogenic species, perhaps to perform basic cellular
functions that are not exclusive to promoting bacterial survival
within host macrophages. This may explain why Myco132 growth
is normal in broth culture yet defective in the macrophage. This is
not unusual, given that the glyoxylate shunt enzyme encoded by
icl, is also not essential in M. tuberculosis, yet required for
intracellular survival [19] [32]. Like Myco132, impaired growth
of icl deficient M. tuberculosis was observed exclusively within
macrophages [19]. Transcription of MSMEG_5817 was detected
in both intracellular and extracellular WT M. smegmatis suggesting
that it is not simply the presence of MSMEG_5817 transcript that
is important in promoting intracellular survival but perhaps its
relative abundance in response to the hostile macrophage
environment. A quantitative analysis of transcript levels is
warranted to determine whether MSMEG_5817 is differentially
regulated during the different phases of macrophage infection.
NF-kB activity co-ordinates the immune response for resistance
to a wide range of pathogens. Activation of NF-kBb y
mycobacterial components (lipoproteins, Ara-LAM, lipomannan
and Man-LAM [33]) has been shown to be critical for clearance
by the host. It is possible that in addition to maintaining basic
bacterial functions, the protein encoded by MSMEG_5817 may
modulate NF-kB activity in infected macrophages in an, as yet,
unidentified manner. Certainly, other pathogenic bacterial
products are known to suppress NF-kB signalling pathways to
promote their survival. For example, by decreasing NF-kB
activity, uropathogenic Escherichia coli and non-pathogenic Salmo-
nella promote internalisation by host cells, inducing minimal
inflammation and subsequent host immune responses compared to
other pathogens [34–35]. Perhaps more relevant to our results, the
toxic Mycobacterium ulcerans product mycolactone (critical for
Figure 8. RT-PCR analysis of wild-type M. smegmatis and Myco132 mRNA. mRNA was isolated from intracellular and extracellular bacteria
and amplified by RT-PCR. Products were resolved on a 1% agarose gel. Lane M, TrackIt
TM 100 bp DNA ladder (Invitrogen). Lanes 1, 3, 5, 7: intracellular
WT, extracellular WT, intracellular Myco132 and extracellular Myco132, respectively. Lanes 2, 4, 6, 8: RT minus controls for intracellular WT, extracellular
WT, intracellular Myco13 and extracellular Myco132, respectively. Lane 9: gDNA positve control. Lane 10: negative PCR control.
doi:10.1371/journal.pone.0031788.g008
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been shown to inhibit NF-kB activity in a wide variety of infected
cells [36].
For many bacteria, the activation of NF-kB is in large part due
to the interaction of different bacterial components with host
TLRs and these interactions have a significant effect on the
establishment of infection. Macrophage responses upon TLR
stimulation relevant to anti-mycobacterial responses include
upregulation of bacterial phagocytosis, phagosome maturation,
expression of pro-inflammatory cytokines, RNI-mediated micro-
bicidal mechanisms and production of cathelicidin, an antimicro-
bial peptide. Thus, it is possible the hypothetical protein encoded
by MSMEG_5817 suppresses or blocks TLR-mediated NF-kB
activity to promote survival of wild type M. smegmatis in vivo.
It is interesting to note that in M. smegmatis,amce1A paralog is
found immediately upstream of MSMEG_5817.I nM. tuberculosis,
mce1A is located in the mce1 operon comprising eight genes [37].
An orthologous operon has also been identified in M. smegmatis
[38] however MSMEG_5818 is not located within this operon,
suggesting that mce1A may have undergone duplication in this
species. The mce locus was first implicated in host cell invasion and
intracellular survival when Arruda et al. showed that expression of
a fragment of M. tuberculosis DNA, conferred the ability of a non-
pathogenic strain of E. coli to enter and survive within HeLa and
macrophage cells [11]. Later studies showed that when this locus
was inactivated in M. bovis BCG, the mce1 mutant strain was
reduced in its ability to enter HeLa cells [13]. A role in establishing
a stable persistent infection was later reported when disruption of
the mce1 operon in M. tuberculosis resulted in a hypervirulent
mutant strain that replicated continuously to kill infected mice
more rapidly than WT M. tuberculosis [14]. The presence of
putative transport domains in mce operons suggests an additional
role for the operons in active transport across the membrane,
possibly in response to environmental signals such as nutrient
requirement and stress [38]. Kumar et al speculate that this may
be the primary role of Mce family proteins in less virulent
mycobacteria such as M. smegmatis [38]. Given that a putative
transport domain was identified in MSMEG_5818, a similar
function in transport should not be discounted.
We can be certain that the phenotype observed in Myco132 and
Myc85 is a consequence of disruption of MSMEG_5817 because
complementation with this gene alone prevents early destruction
in the macrophage. Additionally, the tail to head arrangement of
the two genes makes it unlikely that gene targeting of
MSMEG_5817 would have had any effect on transcription of this
mce paralog. Whether this region is part of a genomic region that is
involved in intracellular survival is unclear. The arrangement of
genes rules out a simple operon arrangement and the significance
of the juxtaposition of these two genes, if any, is unclear given that
this gene arrangement is not conserved in M. tuberculosis.
A possible role for MSMEG_5817 as a SPT/AGT in glyoxylate
metabolism was suggested on the basis of conserved amino acid
homology to SPT/AGT from B. linens. We were unable to
measure any detectable loss of enzymatic activity in the knockout
line compared to WT M. smegmatis even though MSMEG_5817
was shown to be transcribed in the WT strain from our RT-PCR
experiments. This finding led us to re-examine the sequence
similarity studies. AGT (EC 2.6.1.44) and SPT (EC 2.6.1.51) have
been identified in a variety of organisms including yeast,
Arabidopsis and human where all examples have either a
conserved aminotransferase class-III or V domain which is not
present in either MSMEG_5817 nor the B. linens predicted SPT/
AGT protein. In fact no patterns, motifs or domains were
predicted for either sequence using the tools and software available
on the ExPASy (Expert Protein Analysis System) proteomics server
of the Swiss Institute of Bioinformatics (SIB). Moreover, sequence
homology searches between characterised SPT/AGTs from
eukaryotes and prokaryotes revealed no obvious ortholog in M.
smegmatis, M. tuberculosis, M. avium and M. bovis. We conclude that
this homology is an annotation error that should be removed from
the sequence databases.
AGT functions in the detoxification of glyoxylate, an interme-
diate already implicated in latency in mycobacteria. Although
common amongst eukaryotes, AGT has been identified in few
prokaryotes, including Rhodopseudomonas acidophila [39] and Thermo-
coccus litoralis [40]. Although not encoded by MSMEG_5817,
specific AGT enzyme activity was detected in M. smegmatis lysates
suggesting another protein is responsible that cannot be predicted
by sequence similarity. Likely candidates are PLP-dependent
aminotransferase class-III (AGT2) and class-V (AGT1) proteins of
which there are numerous examples in M. smegmatis including
MSMEG_0277, MSMEG_0782, MSMEG_5211 (class-III) and
MSMEG_0978, MSMEG_6246 and MSMEG_6591.
In summary, we found that disruption of MSMEG_5817 from
M. smegmatis by transposon insertion resulted in failure to resist
macrophage killing, leading to impaired survival in infected
macrophages. However, the implications of this finding in
pathogenic mycobacteria still remain unclear. Further investiga-
tion is warranted to determine the precise function of the encoded
protein during infection. Transcriptome, proteome or metabo-
lome-based approaches may be more fruitful in identifying related
genes or metabolic pathways that may be influenced by the actions
of this gene or gene product during infection of macrophages.
Localization of the MSMEG_5817 encoded product, particularly
in pathogenic mycobacteria, may elucidate the host signalling
pathway/s directly targeted during mycobacterial infection and
disease progression. Although studies in M. smegmatis may not
reveal genes specifically involved in virulence or pathogenesis, this
species is a useful model to identify genes that are nonetheless
important for intracellular survival and/or persistence during
mycobacterial infections, and thus may present as attractive targets
for new drug therapies.
Materials and Methods
M. smegmatis and macrophage strains and culture
conditions
All bacterial strains were grown at 39uC in BHI broth
supplemented with 0.05% Tween 80, on BHI agar plates, or in
Middlebrook 7H9 broth with 10% DC enrichment (2% glucose,
0.85% NaCl). Transposon mutant Myco132 and targeted
knockout Myc85 were cultured with the addition of 20 mg/ml
kanamycin and the complementing strain Myc85c with 20 mg/ml
kanamycin and 10 mg/ml gentamicin. Unless otherwise stated, all
broths contained Tween 80 and all liquid and solid media were
supplemented with the appropriate antibiotic. Murine macro-
phage cell line J774A.1 (ATCC TIB-67) was cultured in complete
RPMI comprising RPMI 1640 (GIBCO) supplemented with 10%
heat-inactivated foetal calf serum and 20 mM L-glutamine at
37uC, 5% CO2,i n7 5c m
2 vented T-flasks (Sarstedt).
Isolation of MSMEG_5817::Tn611 mutants and
identification of transposon insertion sites
Myco132 was isolated from a library of Tn611 insertion mutants
of M. smegmatis [23]. The transposon insertion site was determined
by the LMPCR method described by Prod’hom et al (1998) [26].
PCR products representing the genomic sequences flanking each
side of the Tn611 insertion site were sequenced using Big Dye
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Fluorescent Sequencer (Applied Biosystems Inc.).
Construction and complementation of Myc85
MSMEG_5817 and flanking sequences were PCR amplified
using primers 59-GCTCTAGACCCGCGCAGCAGGTAGGG-
GC-39 and 59-CGGGATCCGTTCGTGCCGAGGACCGC-
GAC-39 and cloned into the XbaI and BamHI (underlined) sites
of pUC18 [27]. A non-polar kanamycin resistance cassette was
inserted at the unique BstXI site within MSMEG_5817 and the
entire MSMEG_5817::aphA3 fragment subcloned into the temper-
ature-sensitive vector pPR27 [28] using XbaI/BamHI. This
plasmid was introduced into M. smegmatis by electroporation at
30uC and single crossover strains were selected on kanamycin and
gentamycin plates at 42uC. To derive a double crossover, one of
these clones was grown in LB broth containing kanamycin then
spread on LB plates containing kanamycin and 10% (w/v) sucrose.
Genomic DNA was prepared from kanamycin resistant/genta-
mycin sensitive clones, digested with ClaI/EcoRV and subjected to
Southern hybridization analysis with a MSMEG_5817-specific
probe. To complement Myc85, the 387 bp MSMEG_5817 gene
was amplified from M. smegmatis gDNA using primers 59-
TGGCCAGCCGCCGTAGTGCCGAT-39 and 59-GGAATTC-
TACGGGTCGATACGCACCAC-39 and cloned into the MluNI
and EcoRI sites of pMV261 [29] with a gentamicin resistance
cassette replacing kanamycin resistance conferred by the aph gene
at the NsiI sites. The derived plasmid, pMYC85c was transformed
via electroporation into Myc85. Transformants were selected on
7H10 plates containing kanamycin and gentamicin and designated
Myc85c.
Macrophage infection assay
J774A.1 cells were suspended in complete RPMI and seeded
into 24-well plates at 10
5 cells/well, then incubated overnight at
37uC, 5% CO2. M. smegmatis WT, Myco132, Myc85 and Myc85c
were passed through a 26-gauge needle ten times to disperse
clumps [41] and then added to macrophage cells at an MOI of
10:1. Phagocytosis was permitted during a 1 h incubation at 37uC,
5% CO2, after which macrophage cells were washed thoroughly
with PBS to remove non-phagocytosed mycobacteria. RPMI
containing 10 mg/ml gentamicin to kill extracellular bacteria, was
added to the infected macrophage monolayer and incubated for a
further 0, 4, 8, 24 and 48 h at 37uC, 5% CO2. At each time point
macrophage cells were washed again with PBS and the
intracellular mycobacteria released by lysing macrophage cells
with ice-cold water. The recovered mycobacteria were serially
diluted and plated onto BHI agar supplemented with the
appropriate antibiotic to determine the colony forming units
(CFU). The statistical significance of the data was evaluated by
unpaired Student’s t test.
Luciferase assay
M. smegmatis WT and Myco132 were prepared from stationary
phase cultures by washing in cold PBS and resuspending in 3.5%
formaldehyde for 20 min, followed by additional washes in PBS.
Serial dilutions for enumeration of CFU were performed prior to
the addition of formaldehyde, to allow inoculation of equivalent
cell numbers in the stimulation assays. Three biological replicates
were prepared for each isolate. RAW264.7 mouse macrophage
cells stably expressing the NF-kB-dependent ELAM-luciferase
reporter construct [42] were a kind gift from Ashley Mansell,
Monash Institute of Medical Research, Victoria, Australia.
RAW264.7 cells were seeded at 2610
4 cells/well of a 96-well
flat bottomed tissue culture plate in 100 ml LPS-free RPMI 1640
media (GIBCO) plus 0.5 mg/ml G418, supplemented with 10%
FCS and 1 mM L-glutamine and incubated overnight at 37uC,
5% CO2. Cells were then stimulated with 10
5 cfu mycobacteria in
triplicate, per biological replicate for 3.5 h at 37uC, 5% CO2.
After removing the media, 50 mlo f1 6 Promega passive lysis
buffer was added to each well (5 min at room temperature). 20 ml
from each well was transferred to a white opaque flat-bottomed 96
well plates, and 30 ml Luciferase assay reagent (Promega) added.
Luciferase activity was measured with a Fluro-Optima luminom-
eter. The statistical significance of the data was evaluated by
paired Student’s t test.
In vitro growth and stress assays
To set up in vitro growth curves, a saturated 10 ml starter culture
was diluted to OD600=0.5 in 1 ml BHI and used to inoculate
50 ml BHI. Broths were incubated at 39uC under constant orbital
shaking and OD600 measured at various time points over a 48 h
growth period. For acid stress assays, a 1 in 500 dilution of 10 ml
starter culture was used to inoculate 50 ml BHI at standard pH
(pH 7) and incubated at 39uC with shaking to an OD600 of ,1.0
was reached. For pH stress experiments, cultures were pelleted by
centrifugation at 25006 g for 5 min and washed once with BHI
(pH 7, 5 or 3), and then resuspended in 10 ml BHI (pH 7, 5 or 3)
at OD600=0.5. All broths were again incubated at 39uC with
shaking and 1 ml removed for viable count enumeration after 0, 3
and 6 h. To assess the affect on growth of H2O2 stress, culture
pellets were washed and resuspended in BHI (pH 5). H2O2 was
added to each broth at a final concentration of 0, 2.5, 5, and 7.5 of
10 mM and cultured for 6 h at 39uC with shaking. At 0 and 6 h,
1 ml was removed to determine the viable count. In each case,
results are expressed as a percentage of the CFU observed at 0 h.
Quantification of phagocytosed mycobacteria by FACS
SYTO9 or SYTO62 fluorescent nucleic acid dye (Molecular
Probes) was added to mycobacteria at a final concentration of
200 nM. Mycobacteria were vortexed briefly and incubated at
room temperature for 30 min protected from light. Stained
mycobacteria were collected by centrifugation at 35006 g for
5 min. Pellets were washed seven times with PBS and then
resuspended in RPMI for macrophage infection. Macrophages
were incubated with fluorescently stained mycobacteria (MOI
10:1) at 37uC, 5% CO2 for 1 h. Non-phagocytosed bacteria were
removed by washing the infected macrophage monolayer with
PBS. Infected macrophages were harvested by treatment with
trypsin/EDTA. Cells were centrifuged and the pellets resuspended
in 4% formaldehyde solution. Samples (11,000–15,000 macro-
phage cells) were acquired and analysed using a Beckman Coulter
FC500 flow cytometer and CXP software.
RNA isolation and RT-PCR
For intracellular M. smegmatis samples, 10
8 J774A.1 cells were
seeded in 75 cm
2 vented T-flasks containing 10 ml complete
RPMI and incubated overnight at 37uC, 5% CO2. Macrophages
were infected with M. smegmatis strains (MOI 10:1) which had been
passed through a 26G needle. Infected cells were incubated at
37uC, 5% CO2 for 1 h before non-phagocytosed bacteria were
removed by washing with PBS. Complete RPMI was then
replaced on the infected macrophage monolayer and incubated
for a further 4 h. Extracellular samples were treated in the same
manner, except macrophages were not present during the mock
infection. Intracellular M. smegmatis were harvested from J774A.1
cells by differential lysis as described by Monahan et al [43].
Extracellular M. smegmatis were harvested by centrifugation at
2,5006 g for 5 min and the pellet resuspended in 1 ml Qiagen
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to the manufacturer’s instructions.
For total RNA isolation, 40 mg bacterial pellet was rinsed with
400 ml 0.5% Tween 80 and re-pelleted at 16,2006 g for 1 min.
The bacterial pellet was then resuspended in 720 ml lysis buffer
(20 mM sodium acetate pH 4.4, 0.5% SDS, 1 mM EDTA
pH 8.0, 100 mg/ml proteinase K) and transferred to a 2 ml
screw-capped microfuge tube, containing 0.5 g of 425–600
microns acid-washed glass beads (Sigma) and 1 ml phenol/
chloroform/isoamyl alcohol (125:24:1, pH 4.7). Bacterial cell lysis
was achieved using a reciprocal shaker (Savant B10 101 Fast Prep)
on speed setting 5.0 for three 30 s pulses. The aqueous phase was
collected by centrifugation at 16,2006g for 10 min, removed to a
new microfuge tube, and then re-extracted once with an equal
volume of phenol (pH 4.3)/chloroform/isoamyl alcohol (25:24:1)
and a final time with chloroform/isoamyl alcohol (24:1). The RNA
was precipitated with an equal volume of isopropanol, incubated
for 30 min at 280uC and collected by centrifugation at 16,2006g
for 30 min at 4uC. The pellet was washed with 70% ethanol, dried
under vacuum and resuspended in 30 ml RNase-free water. Total
RNA was treated with 2 units RQ1 DNase I (Promega) for 20 min
at 37uC. The total RNA was then purified further using a Qiagen
RNeasy purification column (Qiagen) according to the manufac-
turer’s instructions.
First strand cDNA was synthesised from 5 mg total RNA and
500 ng random hexamer using Superscript III reverse transcrip-
tase (Invirtogen) according to the manufacturer’s instructions.
PCR was then performed with 5 ml cDNA template in 16reaction
buffer, 1.5 mM MgCl2, 200 mM dNTPs, 10 mM forward and
reverse primers (as described for Myco132 complementation) and
1.25 units Taq DNA polymerase. The PCR conditions were 95uC
hot start for 7 min, followed by 94uC denaturation for 30 s, 55uC
annealing for 30 s and 72uC extension for 1.5 min for 40 cycles
and a final 72uC extension for 5 min. PCR products were
separated on a 1% agarose gel containing 0.4 mg/ml ethidium
bromide and visualised by UV transillumination.
AGT enzyme assays
Enzyme extract was prepared as described by Sakuraba et al
[40] with a few modifications. Briefly, M. smegmatis strains were
grown in 500 ml BHI to an OD600=1.7–1.8. Cells were collected
by centrifugation at 50006g for 20 min and resuspended in 30 ml
lysis buffer (20 mM potassium phosphate buffer [pH7.5], 20%
glycerol, 1 mM EDTA, 0.1 mM DTT, 1 mM phenylmethylsulfo-
nyl fluoride, 10 mg/ml lysozyme) and incubated on ice for
30 min. Samples were then sonicated 3610 sec with a 30 sec
pause on ice between each burst. Samples were centrifuged at
150006g for 40 min and the supernatant used as enzyme extract
for AGT assays. Total protein concentration of the enzyme assay
was determined by Bradford assay [44] using BSA as the standard.
AGT activity assay was adapted from two previously described
methods [45] [40]. Enzyme extract containing 0.2 mg total
protein was incubated at 37uC for 1 h with 20 mM alanine,
5 mM glyoxylate, 20 mM pyridoxal 59-phosphate and 100 mM
potassium phosphate buffer (pH 7.5) in a final volume of 0.8 ml.
The reaction was stopped with the addition of 100 ml 50%
trichloroacetate and centrifuged at 16,2006 g for 10 min. The
supernatant was removed and neutralised with the addition of
1.1 ml 0.27 M Tris-HCl. Pyruvate produced was then assayed
using a Cary 100 Bio UV-visible spectrophotometer to measure
the extinction of NADH in the presence of LDH. This was
achieved by adding 0.4 ml AGT assay sample to a spectropho-
tometer cuvette with 0.23 M Tris-HCl (pH8.4), 0.12 mM NADH,
0.03% BSA and .075 units LDH in a final volume of 3 ml.
Extinctions were measured at 340 nm over 6 min.
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